2-propanol and travoprost

2-propanol has been researched along with travoprost in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrew, R; Bergamini, MV; Davis, AA; Dickerson, J; Landry, T; Mallick, S; Netland, PA; Robertson, SM; Silver, L; Sullivan, EK; Weiner, A1
Albert, DM; Drago, F; Hu, DN; Stjernschantz, JW; Wistrand, PJ1
Huang, P; Liu, W; Wu, L; Zhong, Z1
Gao, YX; Huang, P; Li, B; Wang, ZX; Wu, LL1
Aung, T; Baskaran, M; Chew, PT; Goh, D; Ho, CL; Htoon, HM; Narayanaswamy, A; Nongpiur, ME; Perera, SA; Su, DH; Tun, TA; Wong, TT1

Reviews

1 review(s) available for 2-propanol and travoprost

ArticleYear
Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
    Survey of ophthalmology, 2002, Volume: 47 Suppl 1

    Topics: Amides; Animals; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Eye Color; Gene Expression Regulation; Humans; Iris; Iris Diseases; Latanoprost; Lipids; Melanocytes; Monophenol Monooxygenase; Pigmentation Disorders; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Travoprost; Up-Regulation

2002

Trials

4 trial(s) available for 2-propanol and travoprost

ArticleYear
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    American journal of ophthalmology, 2001, Volume: 132, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prodrugs; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost; Treatment Outcome

2001
Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004%.
    Journal of glaucoma, 2009, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; China; Cloprostenol; Dose-Response Relationship, Drug; Double-Blind Method; Eye Color; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidence; Iris; Iris Diseases; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prognosis; Prospective Studies; Travoprost; Young Adult

2009
A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma.
    Journal of glaucoma, 2011, Volume: 20, Issue:6

    Topics: Aged; Anterior Eye Segment; Antihypertensive Agents; Asian People; China; Cloprostenol; Double-Blind Method; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Intraocular Pressure; Iridectomy; Iris; Laser Therapy; Male; Ophthalmic Solutions; Pilocarpine; Tonometry, Ocular; Travoprost; Treatment Outcome

2011
Argon Laser Peripheral Iridoplasty for Primary Angle-Closure Glaucoma: A Randomized Controlled Trial.
    Ophthalmology, 2016, Volume: 123, Issue:3

    Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iridectomy; Iris; Lasers, Excimer; Male; Middle Aged; Reoperation; Tertiary Care Centers; Tonometry, Ocular; Travoprost; Treatment Outcome

2016